{"id":"amdc-usr-iltamiocel","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection-site complications"},{"rate":null,"effect":"Arrhythmias"},{"rate":null,"effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL4650237","moleculeType":"Cell"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iltamiocel consists of patient-derived skeletal myoblasts that are expanded ex vivo and then injected directly into the scarred myocardium post-infarction. The cells differentiate and integrate into the damaged tissue, promoting structural repair, improving ventricular function, and reducing adverse remodeling. This cell-based approach aims to restore contractile function and prevent progression to heart failure.","oneSentence":"AMDC-USR (iltamiocel) is an autologous skeletal myoblast cell therapy that regenerates damaged heart muscle tissue following myocardial infarction.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:44:34.535Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction with left ventricular dysfunction"}]},"trialDetails":[{"nctId":"NCT03104517","phase":"PHASE3","title":"Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cook MyoSite","startDate":"2019-04-23","conditions":"Stress Urinary Incontinence","enrollment":96},{"nctId":"NCT01893138","phase":"PHASE3","title":"Autologous Muscle Derived Cells for Female Urinary Sphincter Repair","status":"COMPLETED","sponsor":"Cook MyoSite","startDate":"2013-11-21","conditions":"Stress Urinary Incontinence","enrollment":311}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AMDC-USR (iltamiocel)","genericName":"AMDC-USR (iltamiocel)","companyName":"Cook MyoSite","companyId":"cook-myosite","modality":"Biologic","firstApprovalDate":"","aiSummary":"AMDC-USR (iltamiocel) is an autologous skeletal myoblast cell therapy that regenerates damaged heart muscle tissue following myocardial infarction. Used for Acute myocardial infarction with left ventricular dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}